Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB is a generic product labeled by Solco Healthcare US LLC, priced at $0.9013 per EA under NDC 43547046009. Its NADAC has been published 164 times since Jul 5, 2023.
FDA first approved this application on Apr 11, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB
candesartan cilexetil and hydrochlorothiazideStrength
32; 12.5 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547046009
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207455FDA Approved
4/11/2018
TE Code
AB
On Market Since
11/20/2017
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has been published 164 times since Jul 5, 2023, and over the history we have for it it has declined 47.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9013 per EA |
|---|---|
| All-time high | $1.7884 (Dec 13, 2023) |
| All-time low | $0.7888 (Nov 20, 2024) |
| 52-week high | $1.2226 |
| 52-week low | $0.9013 |
| Median price | $1.1725 |
| Average price | $1.2201 |
| Largest weekly change | -41.2% (Nov 20, 2024) |
| Weeks tracked | 164 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB, manufactured by Solco Healthcare US LLC, is $0.9013 per EA (NDC 43547046009), effective Aug 19, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has declined 47.5%. It has been tracked across 164 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
Since Jul 5, 2023, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has ranged from a low of $0.7888 (Nov 20, 2024) to a high of $1.7884 (Dec 13, 2023), with a median of $1.1725 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB (NDC 43547046009) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.